Drug kinetics and alcohol ingestion

Area of Science:

• Pharmacology
• Toxicology
• Drug Metabolism

Background:

• Ethanol ingestion impacts drug pharmacokinetics and pharmacodynamics.
• Interactions are more significant for psychotherapeutic drugs than kinetic changes.
• Alcohol's effect on other drug classes' kinetics is not fully understood.

Purpose of the Study:

• To explore the mechanisms and predictability of alcohol-drug kinetic interactions.
• To highlight the influence of drug binding, hepatic extraction, and distribution space.
• To review the effects of acute and chronic ethanol on drug metabolism.

Main Methods:

• Analysis of drug binding to plasma proteins.
• Assessment of hepatic drug extraction capacity.
• Evaluation of drug distribution space.
• Review of studies on acute and chronic ethanol administration in animals and humans.

Main Results:

• Highly bound drugs with low hepatic clearance (e.g., benzodiazepines, warfarin) are frequently altered by ethanol.
• Acute ethanol inhibits mixed-function oxidase activity, increasing elimination half-life for some drugs (e.g., meprobamate).
• Chronic ethanol increases drug-metabolizing enzymes, potentially decreasing drug half-life, but mechanisms require further study.

Conclusions:

• Alcohol's kinetic interactions with drugs are complex and depend on drug properties.
• Further systematic studies combining kinetic and pharmacodynamic measures are needed.
• Understanding these interactions is crucial for clinical practice.